🍀 Spring Date with Fortune, Prizes with Raffle! Growth Value Phase 1️⃣ 7️⃣ Spring Raffle Carnival Begins!
Seize Spring's Good Luck! 👉 https://www.gate.com/activities/pointprize?now_period=17
🌟 How to Participate?
1️⃣ Enter [Square] personal homepage, click the points icon next to your avatar to enter [Community Center]
2️⃣ Complete Square or Hot Chat tasks such as posting, commenting, liking, speaking to earn growth value
🎁 Every 300 points can raffle once, 10g gold bars, Gate Red Bull gift box, VIP experience card and more prizes waiting for you to win!
Details 👉 https://www.gate.com/ann
Biogen (BIIB) 分析師評級更新:花旗集團上調目標價
花旗集團維持對百健(BIIB)的「中性」評級,但將其目標價上調至215美元,漲幅為16.22%。這一更新反映了過去一個月內多位分析師的積極調整,展現出謹慎樂觀的情緒。百健是一家專注於神經科學和罕見疾病的生物製藥公司,分析師的平均目標價為200.49美元,較其目前股價有2.41%的上行空間。